Which organism is most associated with neonatal meningitis and skin rash?
Most appropriate sample for diagnosing congenital CMV infection in a neonate?
According to neonatal resuscitation protocol, how much oxygen to give in a term neonate with apnea and bradycardia initially?
Which of the following is the most common cause of early-onset neonatal sepsis?
A mother brings her 1-month-old infant to the pediatrician. She says the baby is crying more than usual and is vomiting and does not want to eat. Meningitis is suspected, and a lumbar puncture is done, which shows the following results; Opening pressure = 240 mm H2O (normal = 100-200 mm H2O), WBC count: 1200/mm3, Protein: 200 mg/dL, Glucose: 30 mg/dL, Gram stain: gram-positive rods, Which of the following organisms is most likely responsible for this infant's meningitis?
An appropriate single antibiotic for the empiric treatment of presumed bacterial meningitis in a six month old child would be:
How long should a child be isolated after being diagnosed with bacterial meningitis to prevent further transmission?
A patient at 37 weeks' gestation came to the hospital without antenatal check-up and presented with onset of labor. On examination, the mother is Hep B positive. What management should be given to the neonate?
A neonate develops sepsis with organism showing CAMP test positive. Likely organism?
During delayed cord clamping, how much blood is typically transferred to the neonate?
Explanation: ***HSV-2*** - **Neonatal herpes simplex virus (HSV)** infection, often caused by HSV-2 acquired during vaginal delivery, can manifest with **meningitis** and characteristic **skin vesicles** or a rash. - The rash typically presents as clustered **vesicles on an erythematous base** and can be widespread, making it a key diagnostic clue alongside neurological symptoms. *VZV* - **Varicella-zoster virus (VZV)** can cause neonatal varicella, which presents with a rash but **meningitis** is a much less common complication, typically associated with more severe disseminated disease. - The rash of neonatal varicella usually appears as **macules, papules, vesicles, and scabs** in various stages of healing, rather than the clustered vesicles seen in HSV. *Group B Streptococcus (GBS)* - **GBS** is a leading cause of **neonatal meningitis** and sepsis, but it typically does **not cause a skin rash** in affected infants. - While GBS can cause systemic signs of infection and neurological symptoms, cutaneous manifestations are not characteristic. *Enterovirus 71* - **Enterovirus 71** is known to cause hand, foot, and mouth disease, which includes a **rash** and can, in severe cases, cause **meningitis** or encephalitis. - However, the rash is typically maculopapular or vesicular on the palms, soles, and buttocks, and this association is less common for neonatal meningitis with widespread skin findings compared to HSV.
Explanation: ***Urine within 3 weeks*** - **Urine culture** or **PCR** for CMV collected within the first **3 weeks of life** is the gold standard for diagnosing congenital CMV infection. - This timing is crucial to differentiate congenital infection from postnatal acquisition, as delayed testing can lead to misdiagnosis. *Throat swab* - While CMV can be shed in the **saliva**, a throat swab is less reliable for diagnosing congenital infection within the neonatal period, yielding more false negatives. - Saliva samples are more commonly used if urine is not feasible, but still ideally performed within the **first few weeks** and may require confirmation. *CSF* - **Cerebrospinal fluid (CSF)** testing for CMV is typically performed to assess for **central nervous system involvement** in symptomatic infants, rather than for the primary diagnosis of congenital infection. - A positive CSF CMV PCR indicates neurological complications but is not the primary diagnostic sample for the initial detection of congenital CMV. *Blood PCR* - **Blood PCR** for CMV can be used, but its sensitivity and specificity for diagnosing congenital CMV are generally lower than urine, especially in asymptomatic cases. - Active **CMV replication** in the blood does not always equate to a congenital infection, as newborns can acquire the virus postnatally.
Explanation: ***21%*** - According to **NRP (Neonatal Resuscitation Program) 2020 guidelines**, for **term neonates (≥35 weeks gestation)** requiring resuscitation, the initial recommendation is to use **room air (21% oxygen)** to minimize the risk of hyperoxia and oxidative injury. - Multiple randomized controlled trials have demonstrated that room air is as effective as 100% oxygen for initial resuscitation. - Supplemental oxygen is only added if **oxygen saturation targets** are not met despite adequate ventilation, and should be titrated using **pulse oximetry**. *30%* - This concentration is **higher than room air** and is not the initial recommendation for term neonates needing resuscitation. - Starting with a higher oxygen concentration can lead to **oxidative stress** without immediate benefit. - Higher initial concentrations (21-30%) are reserved for **preterm neonates (<35 weeks)**. *100%* - Administering **100% oxygen** can be harmful to a neonate, potentially causing **oxidative injury** to developing organs, including the lungs, brain, and retina. - This was the old practice but has been **discontinued** based on evidence showing increased mortality and morbidity. - High concentrations are no longer recommended even in severe cases; oxygen should be titrated to saturation targets. *50%* - While lower than 100%, 50% oxygen is still **not the initial recommended concentration** for term neonates in resuscitation protocols. - The goal is to start with **21% oxygen** and gradually increase based on **pulse oximetry monitoring** and target saturation ranges if 21% is insufficient.
Explanation: ***Group B Streptococcus*** - **Group B Streptococcus (GBS)**, or *Streptococcus agalactiae*, is the **most common bacterial cause of early-onset neonatal sepsis** (within the first 7 days of life) in many populations. - Transmission typically occurs vertically from the mother's vaginal flora during birth. - **Intrapartum antibiotic prophylaxis** in GBS-positive mothers has significantly reduced incidence in developed countries. *Escherichia coli* - **E. coli** is the **second most common cause of early-onset sepsis** and the **leading cause in preterm and very low birth weight infants**. - Can be transmitted from the maternal genital tract during delivery. - Associated with higher mortality rates than GBS, particularly in preterm neonates. *Listeria monocytogenes* - While *Listeria monocytogenes* can cause **neonatal sepsis and meningitis**, it is far less common than GBS or E. coli. - Associated with maternofetal transmission from **foodborne infection** in the mother. - Can cause early or late-onset disease. *Klebsiella pneumoniae* - *Klebsiella pneumoniae* is more commonly associated with **late-onset neonatal sepsis**, particularly in **premature or critically ill neonates** in NICU settings. - Often associated with **hospital-acquired infections** and invasive procedures. - In some regions, particularly in developing countries, it can also cause early-onset disease.
Explanation: ***Listeria monocytogenes*** - The presence of **gram-positive rods** in the CSF of a 1-month-old infant with meningitis, coupled with the classic CSF findings (high WBC, high protein, low glucose), is highly suggestive of *Listeria monocytogenes*. - This organism is a significant cause of **neonatal meningitis** and is known for its rod-shaped morphology. *Neisseria meningitidis* - This organism is a **gram-negative diplococcus**, which is inconsistent with the gram stain result of **gram-positive rods**. - While it causes meningitis, its typical presentation and Gram stain morphology differ significantly. *Streptococcus agalactiae* - Also known as **Group B Streptococcus (GBS)**, this is a common cause of neonatal meningitis but is characterized as **gram-positive cocci in chains**, not rods. - The gram stain finding rules out GBS in this case. *Escherichia coli* - *E. coli* is a **gram-negative rod** and can cause neonatal meningitis. - However, the CSF gram stain in this case indicated **gram-positive rods**, which rules out *E. coli*.
Explanation: ***Cefotaxime*** - As a **third-generation cephalosporin**, cefotaxime has excellent penetration into the **cerebrospinal fluid (CSF)** and provides broad-spectrum coverage against common bacterial meningitis pathogens in young children, including *Streptococcus pneumoniae*, *Neisseria meningitidis*, and *Haemophilus influenzae*. - In a 6-month-old child, cefotaxime is an excellent choice for empiric therapy. While both cefotaxime and ceftriaxone are appropriate at this age, cefotaxime is specifically preferred over ceftriaxone in **neonates younger than 28 days** due to concerns about biliary pseudolithiasis and bilirubin displacement, which can worsen jaundice and increase the risk of kernicterus. *Ampicillin* - While effective against *Listeria monocytogenes* (particularly important in neonates and infants <3 months) and Group B *Streptococcus*, ampicillin provides **insufficient coverage** for many other common causes of bacterial meningitis in this age group, particularly penicillin-resistant *Streptococcus pneumoniae* and *Haemophilus influenzae*. - Its use alone as empiric therapy for bacterial meningitis in a 6-month-old would be inadequate, often warranting combination therapy with a third-generation cephalosporin in younger infants. *Cefadroxil* - Cefadroxil is a **first-generation cephalosporin** primarily used for skin, soft tissue, and urinary tract infections. - It has **poor penetration into the CSF** and therefore is not an appropriate choice for treating meningitis. *Cefuroxime* - Cefuroxime is a **second-generation cephalosporin** with limited activity against *Streptococcus pneumoniae* and certain **Gram-negative bacteria** compared to third-generation cephalosporins. - While it has some central nervous system penetration, its efficacy is **inferior to third-generation cephalosporins** like cefotaxime or ceftriaxone for treating bacterial meningitis, especially considering the potential for resistant strains.
Explanation: ***Till 24 hours after starting antibiotics*** - This duration is crucial because, after **24 hours of effective antibiotic therapy**, the bacterial load in the nasopharynx (the primary site of transmission) is significantly reduced. - At this point, the child is generally considered **non-infectious**, and the risk of airborne transmission to others is minimal. *Till 12 hrs after admission* - This period is generally too short to ensure the child is non-infectious, as it may not be enough time for antibiotics to adequately reduce the bacterial load. - Active shedding of bacteria through respiratory droplets can still occur, posing a risk of transmission. *Till cultures become negative* - Waiting for cultures to become negative is an overly stringent and impractical approach to isolation, as it can take several days for culture results. - Clinical guidelines prioritize a more immediate and practical strategy for isolation based on antibiotic efficacy and reduced transmission risk. *Till antibiotics course is complete* - Isolating for the entire course of antibiotics is usually unnecessary and excessive, as the child is typically no longer contagious long before the full course is finished. - Prolonged isolation can create logistical challenges and is not based on the infectious period for bacterial meningitis.
Explanation: ***Hep B vaccine + IG*** - Neonates born to mothers with **positive hepatitis B surface antigen (HBsAg)** should receive both the **hepatitis B vaccine** and **hepatitis B immune globulin (HBIG)** within **12 hours of birth**. - This combination provides both **passive immunity** (from HBIG) and **active immunity** (from the vaccine) to rapidly protect the newborn from perinatal hepatitis B transmission. *Hep B vaccine only* - Administering only the **hepatitis B vaccine** would provide active immunity, but the **onset of protection is slower**, leaving the neonate vulnerable during the immediate high-risk period of exposure. - While essential for long-term protection, the vaccine alone is **insufficient for immediate post-exposure prophylaxis** in a high-risk scenario. *Only IG* - Administering only **HBIG** provides immediate passive immunity, offering short-term protection, but it **does not confer long-lasting immunity**. - Without the vaccine, the infant would remain susceptible to future HBV infection once the passive antibodies wane, which typically occurs within a few months. *First IG then Hep B vaccine after 1 month* - Delaying the **hepatitis B vaccine** by a month would leave the neonate inadequately protected against subsequent exposure or potential continued viral replication after the HBIG's passive immunity declines. - The goal in this high-risk situation is to initiate **both passive and active immunity as quickly as possible** to maximize protection against perinatal transmission.
Explanation: ***Group B Streptococcus*** - **Group B Streptococcus (GBS)**, or *Streptococcus agalactiae*, is the **most common cause of neonatal sepsis** and is the **classic organism** associated with a **positive CAMP test**. - The **CAMP test** (Christie-Atkins-Munch-Petersen) detects synergistic hemolysis between the CAMP factor produced by GBS and *Staphylococcus aureus* beta-lysin, resulting in an **arrowhead-shaped zone of enhanced hemolysis**. - GBS is strongly associated with **early-onset neonatal sepsis** (within first 7 days), transmitted vertically during delivery. - When the CAMP test is mentioned in the context of neonatal sepsis, **GBS is the intended answer** due to its classical association and epidemiological importance. *S. aureus* - *Staphylococcus aureus* can cause **sepsis** in neonates but is **CAMP test negative**. - It provides the beta-lysin used in the CAMP test to detect other organisms but does not produce the CAMP factor itself. *E. coli* - *Escherichia coli* is a **Gram-negative rod** and a frequent cause of **neonatal sepsis** and meningitis. - As a Gram-negative bacterium, *E. coli* is **CAMP test negative**. The CAMP test is specific for certain Gram-positive bacteria. *Listeria* - *Listeria monocytogenes* is **also CAMP test positive**, which can cause diagnostic confusion. - However, it causes a distinct clinical pattern: **granulomatosis infantiseptica**, meningoencephalitis, and is associated with **maternal ingestion of contaminated food**. - Listeria is **less common** than GBS as a cause of neonatal sepsis and is not the classic teaching association for CAMP positivity. - The CAMP positivity of Listeria is **weaker** and shows a different pattern (reverse CAMP) compared to the strong, characteristic arrowhead pattern of GBS.
Explanation: ***50-100 mL*** - **Delayed cord clamping (DCC)** allows for the transfer of a significant volume of **placental blood** back to the neonate. - This typically results in an increase of approximately **50-100 mL** of blood volume in the infant, contributing to improved iron stores and hematocrit levels. *120-150 mL* - This volume is generally **higher than the average transfer** seen with standard delayed cord clamping, though individual variations can occur. - While beneficial, such a large transfer might only occur with **prolonged clamping times** or specific neonatal interventions. *150-180 mL* - This range represents a **substantially larger volume** than what is typically transferred during routine delayed cord clamping. - This volume is **uncommon** and might lead to concerns like **polycythemia** if it occurred. *100-200 mL* - While the lower end of this range (100 mL) can sometimes be achieved, 200 mL is generally **considered excessive** for typical delayed cord clamping. - Such a large volume could contribute to **hyperbilirubinemia** and **polycythemia** in the neonate.
Get full access to all questions, explanations, and performance tracking.
Start For Free